8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
Read more about 8 videos that explain the tension between HIV activists and Big Pharma
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Read more about Fixing the broken patent system: From Marrakech and back again
Storify: Pathways to Access #GSIPA2M
[View the story “Pathways to Access! #GSIPA2M (15-17 Jan 2018)” on Storify] SaveSave
Read more about Storify: Pathways to Access #GSIPA2M
IP and access to medicines: welcome speech
Our inaugural Global Summit on Intellectual Property and Access to Medicines has started today. Read Solange Baptiste’s welcoming speech below,...
Read more about IP and access to medicines: welcome speech
-
Pathways to Access: Our global summit on intellectual property and access to medicines
23 years after the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement was signed in Morocco, our inaugural conference...
Read more about Pathways to Access: Our global summit on intellectual property and access to medicines
ICASA 2017: Optimal HIV treatment for ALL
As the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
Read more about ICASA 2017: Optimal HIV treatment for ALL
New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...
Read more about New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
HIV activists trained on intellectual property and access to medicines
Demystifying intellectual property (IP) and providing advocacy tools. The International Treatment Preparedness Coalition – MENA (ITPC-MENA) with the support...
Read more about HIV activists trained on intellectual property and access to medicines
A victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on atazanavir to Egypt
During the 9th International AIDS Conference (23-26 July 2017), Bristol-Myers Squibb (BMS) and the Medicines Patent Pool (MPP) announced the...
Read more about A victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on atazanavir to Egypt
A generic version of dolutegravir will be made available in Morocco: A major victory for ITPC-MENA
After several months of intense advocacy by treatment activists, ViiV Healthcare has extended its dolutegravir license to Morocco, meaning more...
Read more about A generic version of dolutegravir will be made available in Morocco: A major victory for ITPC-MENA